Stay up-to-date on on the latest happenings at orthopedics' top 10 revenue-producing organizations via the 2026 list. Read More >>
The new recommendations reflect the evolution of SCS literature.
The nominee is a domestic policy official who regularly briefs the president on various health issues.
The authorization strengthens the company's platform for sports medicine, extremities, and soft-tissue fixation.
Tim Czartoski led DePuy Synthes' U.S. orthopedics business served as president of U.S. Surgical and Global R&D at Enovis.
The expanded collaboration will target renewed focus on sustainability, education, and increasing access.
The company debuted its VersaLock Comprehensive Ankle System in the U.S. last week.
This space permits me to share a few items with you that I’ve jotted down as the 2026 reports are reviewed.
